{"id":13389,"date":"2021-06-01T13:13:03","date_gmt":"2021-06-01T12:13:03","guid":{"rendered":"https:\/\/ppr-antibioresistance.inserm.fr\/?p=13389"},"modified":"2025-02-26T15:20:14","modified_gmt":"2025-02-26T14:20:14","slug":"edito-par-francois-lacoste","status":"publish","type":"post","link":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/","title":{"rendered":"\u00c9dito par Fran\u00e7ois Lacoste"},"content":{"rendered":"\n<p>En f\u00e9vrier 2021, un contrat strat\u00e9gique de fili\u00e8re a \u00e9t\u00e9 sign\u00e9 entre les minist\u00e8res de la Sant\u00e9, de l\u2019Industrie et de la Recherche, et les industries de la sant\u00e9. L\u2019un des 6 projets port\u00e9s dans ce contrat interminist\u00e9riel est d\u00e9di\u00e9 \u00e0 la lutte contre l\u2019antibior\u00e9sistance, de fa\u00e7on \u00e0 renforcer l\u2019\u00e9cosyst\u00e8me de l\u2019antibior\u00e9sistance en France et la position de la France sur la sc\u00e8ne internationale.<\/p>\n\n\n\n<p>Ce contrat sera prorog\u00e9 dans les prochains jours avec la signature d\u2019un avenant, reconnaissant ainsi toute l\u2019importance des travaux conduits par ce groupe de travail.<\/p>\n\n\n\n<p>Organis\u00e9 autour de 3 axes \u2013 le d\u00e9veloppement d\u2019un outil web f\u00e9d\u00e9rateur, l\u2019optimisation de la prise en charge des produits de sant\u00e9 d\u00e9di\u00e9s \u00e0 la lutte contre l\u2019antibior\u00e9sistance et la communication, ce groupe de travail inclut de nombreux acteurs publics comme priv\u00e9s. En tant que pilote industriel, cette tribune est pour moi l\u2019occasion de renouveler notre appel \u00e0 candidature \u00e0 rejoindre les travaux conduits pour chacun des 3 axes afin de rassembler le plus grand nombre d\u2019acteurs de la sant\u00e9 humaine comme animale, autour du diagnostic, du traitement, de la vaccination et de la surveillance.<\/p>\n\n\n\n<p>L\u2019une des r\u00e9alisations majeures, sous l\u2019impulsion de l\u2019Inserm, est la cr\u00e9ation et le lancement de <a href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\" target=\"_blank\" rel=\"noopener\">l\u2019Interface nationale ANTIBIORESISTANCE<\/a> visant \u00e0 r\u00e9unir, en un endroit unique, toute l\u2019information relative aux \u00e9quipes priv\u00e9es et publiques travaillant sur le th\u00e8me de l\u2019antibior\u00e9sistance. C\u2019est aussi un lieu d\u2019\u00e9changes et de partage d\u2019informations de tout ordre, notamment scientifique et technologique.<\/p>\n\n\n\n<p>La crise sanitaire Covid \u00e0 laquelle nous sommes confront\u00e9s montre \u00e0 quel point les collaborations entre tous les acteurs sont essentielles au progr\u00e8s scientifique et m\u00e9dical. Nul doute que la lutte contre l\u2019antibior\u00e9sistance n\u00e9cessite une approche collective comparable. Dans cette perspective, renseigner cette plateforme, y \u00eatre actif et moteur est un formidable levier pour d\u00e9velopper la coop\u00e9ration entre tous, public et priv\u00e9, industriels, acad\u00e9miques, scientifiques et professionnels de sant\u00e9.<\/p>\n\n\n\n<p>L\u2019Interface nationale ANTIORESISTANCE est encore enrichie par de nouvelles fonctionnalit\u00e9s avec la mise en ligne de sa version anglaise,&nbsp;permettant notamment de l\u2019ouvrir \u00e0 l\u2019international, d\u2019attirer les talents et de d\u00e9velopper les comp\u00e9tences.<\/p>\n\n\n\n<p>La lutte contre l\u2019antibior\u00e9sistance n\u00e9cessite l\u2019action et la mobilisation de tous. La France peut \u00eatre un acteur de premier plan. Rassemblons-nous autour de cet objectif commun, essentiel pour la sant\u00e9 publique et la pr\u00e9vention des crises sanitaires.<\/p>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<div style=\"height:10px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n\n<h3 class=\"wp-block-heading\">Auteur<\/h3>\n\n\n\n<div class=\"wp-block-media-text is-stacked-on-mobile\" style=\"grid-template-columns:35% auto\"><figure class=\"wp-block-media-text__media\"><img fetchpriority=\"high\" decoding=\"async\" width=\"682\" height=\"1024\" src=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937-682x1024.jpg\" alt=\"Fran\u00e7ois LACOSTE\" class=\"wp-image-12955 size-full\" srcset=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937-682x1024.jpg 682w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937-200x300.jpg 200w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937-768x1154.jpg 768w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937-1022x1536.jpg 1022w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937-1363x2048.jpg 1363w, https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2021\/06\/BIO_0937.jpg 1640w\" sizes=\"(max-width: 682px) 100vw, 682px\" \/><\/figure><div class=\"wp-block-media-text__content\">\n<p><strong>Fran\u00e7ois Lacoste<\/strong><\/p>\n\n\n\n<p><em>Pilote du Comit\u00e9 strat\u00e9gique de fili\u00e8re (CSF) Antibior\u00e9sistance<br>Directeur ex\u00e9cutif, Recherche &amp; d\u00e9veloppement &#8211; bioM\u00e9rieux<\/em><\/p>\n<\/div><\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>En f\u00e9vrier 2021, un contrat strat\u00e9gique de fili\u00e8re a \u00e9t\u00e9 sign\u00e9 entre les minist\u00e8res de la Sant\u00e9, de l\u2019Industrie et de la Recherche, et les industries de la sant\u00e9. L\u2019un des 6 projets port\u00e9s dans ce contrat interminist\u00e9riel est d\u00e9di\u00e9 \u00e0 la lutte contre l\u2019antibior\u00e9sistance, de fa\u00e7on \u00e0 renforcer l\u2019\u00e9cosyst\u00e8me de l\u2019antibior\u00e9sistance en France et [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":30157,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[3341],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u00c9dito par Fran\u00e7ois Lacoste - Interface nationale ANTIBIOR\u00c9SISTANCE<\/title>\n<meta name=\"description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9dito par Fran\u00e7ois Lacoste - Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"og:description\" content=\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l&#039;Antibior\u00e9sistance en France et \u00e0 l&#039;international.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\" \/>\n<meta property=\"og:site_name\" content=\"Interface nationale ANTIBIOR\u00c9SISTANCE\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-01T12:13:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-26T14:20:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1640\" \/>\n\t<meta property=\"og:image:height\" content=\"2464\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Emmanuel Auchet\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emmanuel Auchet\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\"},\"author\":{\"name\":\"Emmanuel Auchet\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\"},\"headline\":\"\u00c9dito par Fran\u00e7ois Lacoste\",\"datePublished\":\"2021-06-01T12:13:03+00:00\",\"dateModified\":\"2025-02-26T14:20:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\"},\"wordCount\":461,\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg\",\"articleSection\":[\"Editoriaux\"],\"inLanguage\":\"fr-FR\"},{\"@type\":[\"WebPage\",\"ItemPage\"],\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\",\"name\":\"\u00c9dito par Fran\u00e7ois Lacoste - Interface nationale ANTIBIOR\u00c9SISTANCE\",\"isPartOf\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg\",\"datePublished\":\"2021-06-01T12:13:03+00:00\",\"dateModified\":\"2025-02-26T14:20:14+00:00\",\"description\":\"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.\",\"breadcrumb\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg\",\"width\":1640,\"height\":2464},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Editoriaux\",\"item\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"\u00c9dito par Fran\u00e7ois Lacoste\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"name\":\"Interface nationale ANTIBIOR\u00c9SISTANCE\",\"description\":\"PPR Antibior\u00e9sistance - Inserm\",\"publisher\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization\",\"name\":\"Inserm\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"contentUrl\":\"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg\",\"width\":1,\"height\":1,\"caption\":\"Inserm\"},\"image\":{\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8\",\"name\":\"Emmanuel Auchet\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9dito par Fran\u00e7ois Lacoste - Interface nationale ANTIBIOR\u00c9SISTANCE","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9dito par Fran\u00e7ois Lacoste - Interface nationale ANTIBIOR\u00c9SISTANCE","og_description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","og_url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/","og_site_name":"Interface nationale ANTIBIOR\u00c9SISTANCE","article_published_time":"2021-06-01T12:13:03+00:00","article_modified_time":"2025-02-26T14:20:14+00:00","og_image":[{"width":1640,"height":2464,"url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg","type":"image\/jpeg"}],"author":"Emmanuel Auchet","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Emmanuel Auchet","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#article","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/"},"author":{"name":"Emmanuel Auchet","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8"},"headline":"\u00c9dito par Fran\u00e7ois Lacoste","datePublished":"2021-06-01T12:13:03+00:00","dateModified":"2025-02-26T14:20:14+00:00","mainEntityOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/"},"wordCount":461,"publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg","articleSection":["Editoriaux"],"inLanguage":"fr-FR"},{"@type":["WebPage","ItemPage"],"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/","name":"\u00c9dito par Fran\u00e7ois Lacoste - Interface nationale ANTIBIOR\u00c9SISTANCE","isPartOf":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage"},"thumbnailUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg","datePublished":"2021-06-01T12:13:03+00:00","dateModified":"2025-02-26T14:20:14+00:00","description":"Informations, \u00e9v\u00e8nements et actualit\u00e9s autour de l'Antibior\u00e9sistance en France et \u00e0 l'international.","breadcrumb":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#primaryimage","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2025\/02\/Francois-Lacoste.jpg","width":1640,"height":2464},{"@type":"BreadcrumbList","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/edito-par-francois-lacoste\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/"},{"@type":"ListItem","position":2,"name":"Editoriaux","item":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/edito\/"},{"@type":"ListItem","position":3,"name":"\u00c9dito par Fran\u00e7ois Lacoste"}]},{"@type":"WebSite","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#website","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","name":"Interface nationale ANTIBIOR\u00c9SISTANCE","description":"PPR Antibior\u00e9sistance - Inserm","publisher":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#organization","name":"Inserm","url":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","contentUrl":"https:\/\/ppr-antibioresistance.inserm.fr\/wp-content\/uploads\/2020\/05\/logo-inserm-ppra.svg","width":1,"height":1,"caption":"Inserm"},"image":{"@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/#\/schema\/person\/dddace6035f5329dbab637f17f7a1ff8","name":"Emmanuel Auchet"}]}},"publishpress_future_action":{"enabled":false,"date":"2026-05-06 21:26:24","action":"change-status","newStatus":"private","terms":[],"taxonomy":"category"},"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/13389"}],"collection":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/comments?post=13389"}],"version-history":[{"count":6,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/13389\/revisions"}],"predecessor-version":[{"id":30155,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/posts\/13389\/revisions\/30155"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media\/30157"}],"wp:attachment":[{"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/media?parent=13389"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/categories?post=13389"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ppr-antibioresistance.inserm.fr\/fr\/wp-json\/wp\/v2\/tags?post=13389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}